Search Results - "Younis, Mahmoud A"

Refine Results
  1. 1

    Clinical translation of nanomedicines: Challenges, opportunities, and keys by Younis, Mahmoud A., Tawfeek, Hesham M., Abdellatif, Ahmed A.H., Abdel-Aleem, Jelan A., Harashima, Hideyoshi

    Published in Advanced drug delivery reviews (01-02-2022)
    “…[Display omitted] Despite the massive interest and recent developments in the field of nanomedicine, only a limited number of formulations have found their way…”
    Get full text
    Journal Article
  2. 2

    Ultra-small lipid nanoparticles encapsulating sorafenib and midkine-siRNA selectively-eradicate sorafenib-resistant hepatocellular carcinoma in vivo by Younis, Mahmoud A., Khalil, Ikramy A., Elewa, Yaser H.A., Kon, Yasuhiro, Harashima, Hideyoshi

    Published in Journal of controlled release (10-03-2021)
    “…Hepatocellular carcinoma (HCC) is a fatal disease with limited therapeutic choices. The stroma-rich tumor microenvironment hinders the in vivo delivery of most…”
    Get full text
    Journal Article
  3. 3

    Lipid Nanoparticles for Cell-Specific in Vivo Targeted Delivery of Nucleic Acids by Khalil, Ikramy A., Younis, Mahmoud A., Kimura, Seigo, Harashima, Hideyoshi

    Published in Biological & pharmaceutical bulletin (01-04-2020)
    “…The last few years have witnessed a great advance in the development of nonviral systems for in vivo targeted delivery of nucleic acids. Lipid nanoparticles…”
    Get full text
    Journal Article
  4. 4

    Biomedical Applications of Quantum Dots: Overview, Challenges, and Clinical Potential by Abdellatif, Ahmed A H, Younis, Mahmoud A, Alsharidah, Mansour, Al Rugaie, Osamah, Tawfeek, Hesham M

    Published in International journal of nanomedicine (01-05-2022)
    “…Despite the massive advancements in the nanomedicines and their associated research, their translation into clinically-applicable products is still below…”
    Get full text
    Journal Article
  5. 5

    Self-homing nanocarriers for mRNA delivery to the activated hepatic stellate cells in liver fibrosis by Younis, Mahmoud A., Sato, Yusuke, Elewa, Yaser H.A., Kon, Yasuhiro, Harashima, Hideyoshi

    Published in Journal of controlled release (01-01-2023)
    “…Herein, we report on the development of a platform for the selective delivery of mRNA to the hard-to-transfect Activated Hepatic Stellate Cells (aHSCs), the…”
    Get full text
    Journal Article
  6. 6

    Reprogramming activated hepatic stellate cells by siRNA-loaded nanocarriers reverses liver fibrosis in mice by Younis, Mahmoud A., Sato, Yusuke, Elewa, Yaser H.A., Harashima, Hideyoshi

    Published in Journal of controlled release (01-09-2023)
    “…We report on a novel strategy for treating liver fibrosis through reprogramming activated Hepatic Stellate Cells (aHSCs) into quiescent Hepatic Stellate Cells…”
    Get full text
    Journal Article
  7. 7

    A Multifunctional Lipid-Based Nanodevice for the Highly Specific Codelivery of Sorafenib and Midkine siRNA to Hepatic Cancer Cells by Younis, Mahmoud A, Khalil, Ikramy A, Abd Elwakil, Mahmoud M, Harashima, Hideyoshi

    Published in Molecular pharmaceutics (03-09-2019)
    “…Hepatocellular carcinoma (HCC), a common deadly malignancy, requires novel therapeutic strategies to improve the survival rate. Combining chemotherapy and gene…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Techno-economical study of solar water pumping system: optimum design, evaluation, and comparison by Kazem, Hussein A., Quteishat, Anas, Younis, Mahmoud A.

    “…Solar water pumping systems are fundamental entities for water transmission and storage purposes whether it is has been used in irrigation or residential…”
    Get full text
    Journal Article
  10. 10

    Novel sublingual tablets of Atorvastatin calcium/Trimetazidine hydrochloride combination; HPTLC quantification, in vitro formulation and characterization by Atia, Noha N., Tawfeek, Hesham M., Rageh, Azza H., El-Zahry, Marwa R., Abdelfattah, Ahmed, Younis, Mahmoud A.

    Published in Saudi pharmaceutical journal (01-05-2019)
    “…Ischemic heart disorders and accumulation of lipids in blood vessels could contribute to angina pectoris. Therefore, the aim of this study was to formulate…”
    Get full text
    Journal Article
  11. 11

    Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines by Nakamura, Takashi, Sato, Yusuke, Yamada, Yuma, Abd Elwakil, Mahmoud M., Kimura, Seigo, Younis, Mahmoud A., Harashima, Hideyoshi

    Published in Advanced drug delivery reviews (01-09-2022)
    “…[Display omitted] A new era of nanomedicines that involve nucleic acids/gene therapy has been opened after two decades in 21st century and new types of more…”
    Get full text
    Journal Article
  12. 12

    MCT4 knockdown by tumor microenvironment-responsive nanoparticles remodels the cytokine profile and eradicates aggressive breast cancer cells by Abdellatif, Ahmed A.H., Bouazzaoui, Abdellatif, Tawfeek, Hesham M., Younis, Mahmoud A.

    Published in Colloids and surfaces, B, Biointerfaces (01-06-2024)
    “…Breast cancer is a wide-spread threat to the women’s health. The drawbacks of conventional treatments necessitate the development of alternative strategies,…”
    Get full text
    Journal Article
  13. 13

    Impact of the functional coating of silver nanoparticles on their in vivo performance and biosafety by Tawfeek, Hesham M., Younis, Mahmoud A., Aldosari, Basmah Nasser, Almurshedi, Alanood Sunhat, Abdelfattah, Ahmed, Abdel-Aleem, Jelan A.

    Published in Drug development and industrial pharmacy (04-05-2023)
    “…Silver nanoparticles (AgNPs) have become an interesting therapeutic modality and drug delivery platform. Herein, we aimed to investigate the impact of…”
    Get full text
    Journal Article
  14. 14

    Understanding Gene Involvement in Hepatocellular Carcinoma: Implications for Gene Therapy and Personalized Medicine by Younis, Mahmoud A, Harashima, Hideyoshi

    Published in Pharmacogenomics and personalized medicine (01-01-2024)
    “…Hepatocellular carcinoma (HCC) is the dominant type of liver cancers and is one of the deadliest health threats globally. The conventional therapeutic options…”
    Get full text
    Journal Article
  15. 15

    Targeted Nanoparticles: the Smart Way for the Treatment of Colorectal Cancer by Abdellatif, Ahmed A. H., Alshubrumi, Abdulmajeed S., Younis, Mahmoud A.

    Published in AAPS PharmSciTech (24-01-2024)
    “…Colorectal cancer (CRC) is a widespread cancer that starts in the digestive tract. It is the third most common cause of cancer deaths around the world. The…”
    Get full text
    Journal Article
  16. 16

    Lipid nanoparticles technology in vaccines: Shaping the future of prophylactic medicine by Abdellatif, Ahmed A.H., Younis, Mahmoud A., Alsowinea, Abdullah F., Abdallah, Emad M., Abdel-Bakky, Mohamed S., Al-Subaiyel, Amal, Hassan, Yasser A.H., Tawfeek, Hesham M.

    Published in Colloids and surfaces, B, Biointerfaces (01-02-2023)
    “…Throughout decades, the intrinsic power of the immune system to fight pathogens has inspired researchers to develop techniques that enable the prevention or…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Gene Therapy for Hepatocellular Carcinoma: Highlighting the Journey from Theory to Clinical Applications by Younis, Mahmoud A., Khalil, Ikramy A., Harashima, Hideyoshi

    Published in Advanced therapeutics (01-11-2020)
    “…Treatment for hepatocellular carcinoma (HCC) is currently limited to early stages where surgical intervention is applicable. Meanwhile, the response for most…”
    Get full text
    Journal Article
  19. 19

    Sulpiride gastro-retentive floating microsponges; analytical study, in vitro optimization and in vivo characterization by Younis, Mahmoud A., El-Zahry, Marwa R., Tallat, Mahmoud A., Tawfeek, Hesham M.

    Published in Journal of drug targeting (20-04-2020)
    “…Sulpiride (SUL), anti-dopaminergic drug, has a specific site for absorption located in the upper portion of the gastrointestinal tract hence, its oral delivery…”
    Get full text
    Journal Article
  20. 20

    Chitosan-capped silver nanoparticles with potent and selective intrinsic activity against the breast cancer cells by Abdellatif, Ahmed A. H., Abdelfattah, Ahmed, Younis, Mahmoud A., Aldalaan, Saed M., Tawfeek, Hesham M.

    Published in Nanotechnology reviews (Berlin) (04-05-2023)
    “…Herein, we report on the development of chitosan-capped silver nanoparticles (AgNPs-CHI) with an intrinsic activity against breast cancer cells. Following…”
    Get full text
    Journal Article